The next standard in SCS lead placement starts here.

We're building the platform that brings real-time functional insight into the OR. Take a look at where Cartis Neuro is headed.

Connect With Us

30–40%

of current SCS systems fail to deliver lasting relief

79%

of SCS cases require revision surgery within 12 months

$40K

average cost of a single revision procedure

Figures reflect published functional-mapping and SCS outcomes literature, not CordMap SCS™-specific clinical results. CordMap SCS™ has not received market clearance from the FDA or any other regulatory authority.

Why Now

Surgeons place SCS leads by anatomy. We're making it functional.

A real gap in the OR

Fluoroscopy shows bone, not the cord itself. Today's tools leave physicians making placement decisions without functional feedback.

Built for the workflow

CordMap SCS™ is designed to support clinical decision-making in real time, without adding steps or specialized staff to the case.

A growing category

Intraoperative functional mapping is gaining traction across neuromodulation. We're positioning early, with a clear path through FDA pre-submission.

Let's connect.

Investors and partners interested in Cartis Neuro, we'd like to hear from you.